Asgard Therapeutics (ASGD) Appoints Wolfram Brugger as CMO
Published on 4/14/2026
AI Summary
Summarized by AI from the source belowAsgard Therapeutics (ASGD) announced the appointment of Wolfram Brugger as chief medical officer. This change is expected to enhance the company’s clinical development capabilities. Brugger brings extensive experience in medical leadership, having previously held senior roles in other biotech firms. This move may improve stakeholder confidence and strategic direction within the company, reflecting on future growth potential.
Get the free market brief
Top stories and analysis, summarized. No spam, unsubscribe anytime.
